U.S. Medical Equipment Stock News

NasdaqGS:CLOV
NasdaqGS:CLOVHealthcare

Clover Health (CLOV) Stock Reprices As Profitability Finally Starts To Stick

Clover Health stock rose 12.7% to about US$4.67 into the close, and the mood shift is all about profitability finally showing up in the numbers. The company reported Q2 net income of US$28 million on revenue of US$743 million, its second straight profitable quarter, which is notable for a Medicare Advantage insurer that has spent years in the red. The market appears focused on that earnings shift and the raised 2026 guidance for revenue and adjusted EBITDA. The key question for investors now...
NYSE:KMPR
NYSE:KMPRInsurance

Kemper (KMPR) Stock Shrugs Off Impairment As Underwriting Repair Emerges

Kemper stock inched up about 2% to roughly US$29.83 the day after earnings, which is a remarkably calm response for a quarter that included a US$464.8m net loss driven by a large non cash goodwill impairment in specialty auto. The market seems to be treating that hit as accounting noise rather than a fresh blow to the franchise. The real story for you is the split personality in this report. On one side are heavy headline losses and an increased debt to capital ratio of 28.3%. On the other...
NYSE:BROS
NYSE:BROSHospitality

Dutch Bros (BROS) Stock Price Faces Valuation Scrutiny After Margin Pressure

Dutch Bros came into this earnings season priced for perfection, then handed investors a reality check. The stock dropped about 19% to US$53.32 the first trading day after results, even as the company posted Q2 revenue of US$550.9m and basic earnings per share of US$0.28. For a coffee chain long sold as a high growth story, that gap between a sharp selloff and solid headline numbers is the core of today’s debate. Is Dutch Bros still priced for perfection after this drop, or do these earnings...
NYSE:CACI
NYSE:CACIProfessional Services

CACI (CACI) Stock Jumps As Tech Pivot Gains Traction

The market just put CACI International on a pedestal. The stock exploded about 21% in a single session, a huge move for a government technology and services contractor. That kind of jump suggests emotion first, questions later. The headline that stirred this reaction is clear. CACI reported a strong fiscal 2026 finish with fourth quarter revenue of about US$2.7b and basic earnings per share above US$7, alongside a full year that reflected its shift toward higher margin technology work. The...
NasdaqGS:TDUP
NasdaqGS:TDUPSpecialty Retail

ThredUp (TDUP) Stock Price Cracks After Guidance Clouds Margin Progress

ThredUp stock just lost half its value in a single session, closing at about US$3.09 after a brutal 51% one day hit. The selloff looks less like a calm reassessment and more like a rush for the exits, even though the headline from Q2 is clear. The online resale player produced US$90.8m in revenue with a gross margin near 80% and turned in positive adjusted earnings before interest, tax, depreciation and amortization. That mix of high gross margin and positive adjusted EBITDA, set against a...
NasdaqGS:CHRD
NasdaqGS:CHRDOil and Gas

Chord Energy (CHRD) Stock Cash Return Pledge Recasts A Quiet Profit Surge

Chord Energy stock added 1.9% to close at US$132.47, a calm move for a quarter that delivered a jolt in the numbers. The market is treating this like a routine beat. The earnings print was anything but routine. The real story sits in profit power. Second quarter basic earnings per share jumped to US$9.38 on revenue of US$2.17b, supported by US$414m in adjusted free cash flow and a pledge to lift shareholder payouts to at least 75% of that cash. The question now is whether a modest one day pop...
NYSE:ZIP
NYSE:ZIPInteractive Media and Services

ZipRecruiter (ZIP) Stock Faces Monetization Questions After Profit Swing

ZipRecruiter just delivered the kind of surprise that makes a 10% jump in the stock look almost cautious. Coming into the release, shares had been grinding higher over the past month but still priced the company as a modestly valued online jobs marketplace with questions around earnings quality and a stretched balance sheet. The headline this quarter is a sharp profit swing and cleaner income statement. Q2 net income landed at US$43.4m on US$118.1m of revenue, helped by a gain on debt...
NYSE:DHX
NYSE:DHXInteractive Media and Services

DHI Group (DHX) Stock Profit Streak Meets Fading Revenue Momentum

The market barely flinched at DHI Group today. The stock slipped 1.4% to about $4.12, even though the latest quarter showed something sentiment has been fighting for a while: sustained profitability. Q2 basic earnings per share landed just above $0.06 on a little over $31 million of revenue, marking another profitable quarter after a long stretch of losses. For a recruitment focused tech platform with a high trailing P/E and modest revenue base, that shift in earnings quality is the real...
NYSE:XYZ
NYSE:XYZDiversified Financial

Block (SQ) Stock Drops As Margin Gains Clash With Profit Quality

Block walked into this earnings print with a stock that had been grinding higher over the past three months, then saw shares drop about 6% to US$79.07 on the day. That is a sharp reset for a company often viewed as a long term growth story in digital payments and consumer finance. The headline this quarter is profitability. Block reported Q2 basic earnings per share of US$0.15 on revenue of about US$6.62b, alongside record adjusted operating margins and full year guidance raised on gross...
NasdaqGS:COKE
NasdaqGS:COKEBeverage

Coca-Cola Consolidated (COKE) Stock Rises As Margin Squeeze Clouds Revenue Strength

Coca-Cola Consolidated stock closed up 1.9% at US$188.22, even though the past week left holders slightly underwater. The move came on the back of a Q2 earnings print that put profit quality in the spotlight rather than just headline growth. The key story is margin and profit squeeze. Trailing 12 month net profit margin sits at 7.2%, down from 8.4% a year earlier, and earnings over the most recent year moved against a five year earnings growth rate of 19%. Short term traders reacted...
NasdaqGS:SDGR
NasdaqGS:SDGRHealthcare Services

Schrödinger (SDGR) Stock Rallies On Profit Turn But Durability Questions Remain

Schrödinger jumped about 9% today to US$17.82 as investors rushed to reprice a story that has been dominated by long running losses. The headline this quarter is a clean turn into the black on net income with US$6.0 million on US$58.9 million of revenue, helped by a gain tied to the sale of collaborator Ajax. That marks a sharp contrast with the heavy loss in the prior quarter and it matters for a stock still valued at roughly 5.1x trailing sales. The real question for you now is whether this...
NYSE:EXP
NYSE:EXPBasic Materials

Is Eagle Materials (EXP) Undervalued On Mixed Earnings And Governance Changes?

Eagle Materials (EXP) has drawn attention after first quarter 2026 results showed sales of US$650.97 million and net income of US$102.13 million, alongside a reaffirmed US$0.25 quarterly dividend and fresh shareholder governance changes. See our latest analysis for Eagle Materials. Eagle Materials' share price has softened recently, with a 1-day share price return that declined 3.17% following the earnings release, while the 1-year total shareholder return is down 5.31%. However, the 3-year...
NasdaqGS:GT
NasdaqGS:GTAuto Components

Goodyear (GT) Stock Slips As Losses Persist Despite Margin Repair

Goodyear Tire & Rubber shares slipped 2.5% to US$6.77 today, which is a muted move given what the new numbers say about the core business. The headline is not a revenue surprise; it is the earnings grind. Goodyear is still posting quarterly losses, yet the Q2 loss per share narrowed compared with Q1 and segment operating income stayed in positive territory. For a stock that has already drifted lower over the past month, today’s reaction looks more like fatigue than panic. The real story sits...
NYSE:KRO
NYSE:KROChemicals

Kronos Worldwide (KRO) Stock Rebounds On Profit Return But Losses Linger

Kronos Worldwide stock rose 32.2% to about US$8.21 after its latest earnings, a sharp move for a pigment producer that had reported losses over the last year. The market responded to a return to profit in the quarter, with basic earnings per share of roughly US$0.13 and net income of US$15.2m. The short-term reaction is clear. The bigger question for you is whether this single profitable quarter marks the beginning of a recovery for a business that still shows trailing 12 month earnings in...
NYSE:RCUS
NYSE:RCUSBiotechs

Arcus Biosciences (RCUS) Stock Can Casdatifan Carry Mounting Losses

Arcus Biosciences came into this earnings print as a high expectation biotech story with a rich P/S multiple and a stock that had already climbed 11.7% over the past three months. The 2.3% pop to about US$28.35 after the Q2 release indicates that investors liked what they saw on the surface, but the real headline is different. Revenue reached US$41m while the company still reported a sizeable US$91m net loss. For a drug developer built on future cash flows, that mix of growing top line and...
NasdaqGS:WMG
NasdaqGS:WMGEntertainment

Warner Music Group (WMG) Stock Rises As Margins Reset The Debate

Warner Music Group stock has been stuck in reverse for months, yet the latest earnings forced the market to pause that downtrend. Shares ticked up 1.8% to US$26.46 after the Q3 release, even though the stock is still down about 21% over the past three months. That small bounce sits on top of a very different story in the numbers. The real headline is margin power. Revenue reached US$1,864m for the quarter while net income came in at US$204m, and trailing net margin now stands at 9.2%. For a...
NYSE:WES
NYSE:WESOil and Gas

Western Midstream Partners (WES) Stock Faces Margin Squeeze Despite Guidance Lift

Western Midstream Partners has spent the past year wearing the label of an income heavy midstream play with a valuation gap and margin questions. Today the stock inched up about 2% after earnings, a muted move considering the headline numbers. Revenue reached about US$1.22b for the quarter and basic earnings per unit landed just under US$1, both solid figures for a pipeline and gathering business where cash flow consistency matters. The real story for you as an investor is the expectation...
NYSE:ASB
NYSE:ASBBanks

Associated Banc-Corp (ASB) Could Be 7% Undervalued On Strong Q2 Earnings And Dividends

Associated Banc-Corp (ASB) is back in focus after second quarter results showed higher net interest income and net income year over year, along with affirmed common and preferred dividends that keep income minded investors watching the stock closely. See our latest analysis for Associated Banc-Corp. At a share price of $31.16, Associated Banc-Corp has moved higher over the year, with a year to date share price return of 20.96% and a 1 year total shareholder return of 35.77%. This suggests...
NasdaqCM:BTDR
NasdaqCM:BTDRSoftware

Bitdeer (BTDR) Stock Looks Fairly Priced Despite Big AI Expansion Plans

Bitdeer Technologies Group stock has declined 18.7% over the past year, yet the latest valuation checks suggest it is roughly in line with where a typical market multiple screen might place it rather than standing out as an obvious bargain. Over the past 12 months, Bitdeer Technologies Group shares are down 18.7%, which means recent investors have faced a clear drag on returns even before thinking about valuation. The long term, multi billion dollar AI data center lease in Norway can support...
NYSE:NSP
NYSE:NSPProfessional Services

Why Insperity (NSP) Is Down 5.1% After Narrow 2026 Profit Outlook And Buyback Completion - And What's Next

In the past quarter, Insperity, Inc. reported second‑quarter 2026 sales of US$1,686 million and net income of US$4 million, turning around from a net loss a year earlier, and issued guidance that ranges from a modest loss to a small profit for the third quarter and US$28 million to US$51 million in net income for full‑year 2026. Alongside completing a long‑running US$1.10 billion share repurchase program and filing an US$85.18 million ESOP‑related shelf registration, management highlighted...
NYSE:WAL
NYSE:WALBanks

Western Alliance (WAL) Stock Could Still Be Discounted After A 73% Run

Western Alliance Bancorporation stock has delivered a 73.2% total return over the past three years, yet the current checks still suggest the shares lean cheap rather than fully priced in. With the company now emphasizing share buybacks alongside loan growth and deposit optimization, investors are weighing whether the recent performance already reflects these shifts or if there is still value on the table. A 73.2% return over three years marks a strong outcome for holders, which raises the...
NasdaqGS:IBRX
NasdaqGS:IBRXBiotechs

ImmunityBio (IBRX) Stock May Trade At A Premium To Fair Value

ImmunityBio stock has delivered a very strong 321.9% gain over the past three years, yet the current checks on valuation and market pricing point to a company that does not clearly stand out as either a bargain or obviously overpriced. The 321.9% return over three years is very large, which makes today’s entry price more important for investors who are considering the next phase of the story. Recent approvals and regulatory progress for ANKTIVA can support confidence in ImmunityBio’s revenue...
NYSE:WAT
NYSE:WATLife Sciences

Waters (WAT) Is Up 5.1% After Raising 2026 Revenue Guidance Amid Integration Progress – What’s Changed

In early August 2026, Waters Corporation reported second-quarter results showing sales of US$1.65 billion versus US$771 million a year earlier, alongside a shift from net income of US$147 million to a net loss of US$136 million, and issued third-quarter and full-year 2026 revenue guidance of US$1.75–1.76 billion and US$6.42–6.48 billion respectively. Management highlighted 9% organic constant currency growth, strong performance in pharmaceutical and academic markets, faster growth in newly...
NYSE:BF.B
NYSE:BF.BBeverage

Is Brown Forman (BF.B) Fully Valued On The Failed Buyout Offer?

Buyout proposal falls through while dividends continue Sazerac Company cancelled its proposed US$32 per share, roughly US$15b cash acquisition of Brown-Forman (BF.B) on July 26, 2026, after Brown family interests deemed the offer misaligned with their long term vision. See our latest analysis for Brown-Forman. Brown-Forman shares now trade at US$28.38, with a 1 month share price return of 10.21% and year to date gain of 8.57%. However, the 1 year total shareholder return has declined 3.81%...